|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
53,520,000 |
Market
Cap: |
36.18(M) |
Last
Volume: |
446,593 |
Avg
Vol: |
445,364 |
52
Week Range: |
$0.676 - $0.676 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
376,024 |
573,024 |
573,024 |
573,024 |
Total Buy Value |
$341,102 |
$521,155 |
$521,155 |
$521,155 |
Total People Bought |
1 |
1 |
1 |
1 |
Total Buy Transactions |
24 |
32 |
32 |
32 |
Total Shares Sold |
0 |
30,110 |
30,110 |
30,110 |
Total Sell Value |
$0 |
$26,460 |
$26,460 |
$26,460 |
Total People Sold |
0 |
2 |
2 |
2 |
Total Sell Transactions |
0 |
5 |
5 |
5 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Smith Lawrence Russell |
VP, Vaccine Research |
|
2014-07-11 |
4 |
AS |
$1.16 |
$2,225 |
D/D |
(1,912) |
191,301 |
|
- |
|
Bilinsky Igor |
Senior VP, Corporate Devt |
|
2014-07-11 |
4 |
AS |
$1.16 |
$1,554 |
D/D |
(1,335) |
141,483 |
|
- |
|
Morrow George J |
Director |
|
2014-05-22 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
19,847 |
|
- |
|
Merton Robert C |
Director |
|
2014-05-22 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
83,281 |
|
- |
|
Lyons Gary A |
Director |
|
2014-05-22 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
70,781 |
|
- |
|
Sherwin Stephen A |
Director |
|
2014-05-22 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
14,503 |
|
- |
|
Douglas R Gordon |
Director |
|
2014-05-22 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
100,781 |
|
- |
|
Beleson Richard M |
Director |
|
2014-05-22 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
14,578 |
|
- |
|
258 Records found
|
|
Page 11 of 11 |
|
|